在COPD中准多个病理生理轴:纳米材料的进步
Qianyue Zhang1, Shuanglan Xu2, Chunyan Yang3
1Kunming Medical University, Kunming, Yunnan, 650500, People's Republic of China.
本综述通过检查其核心病理生理学来确定慢性阻塞性肺病 (COPD) 的纳米干预目标. 它探索纳米载体系统,以改善药物输送和克服当前的治疗挑战.
科学领域:
- 纳米医学是一种纳米医学.
- 肺部医学 肺部医学
- 生物技术是生物技术.
背景情况:
- 慢性阻塞性肺病 (COPD) 由于其渐进性和有限的治疗疗效,给全球健康带来了重大挑战.
- 目前的COPD疗法由于药物在肺部的生物可用性较差以及异于目标的全身毒性而受到影响.
- 解决这些局限性需要新的治疗策略,针对COPD复杂的病理生理学.
研究的目的:
- 系统地识别和分析特定于COPD病理生理学的纳米干预目标.
- 批判性地评估现有的呼吸道适应性纳米载体系统用于COPD治疗.
- 为推进纳米干预措施向COPD精密治疗提供路线图.
主要方法:
- 在四个病理生理轴上系统地识别COPD特定的纳米干预目标:炎症,氧化还原失衡,蛋白酶-抗蛋白酶稳态和气道改造.
- 对纳米载体系统如聚合物纳米粒子 (PLGA-PEG) 和脂质纳米粒子 (LNPs) 的批判性评估.
- 对纳米粒子疗效,准效率和肺部输送中的生物相容性现有文献的审查.
主要成果:
- 确定了COPD核心病理生理机制中的关键纳米干预目标.
- 使用PLGA-PEG纳米颗粒 (*p* < 0.001) 证明增强了中性粒细胞向效率 (6.5倍).
- 使用脂质纳米粒子 (LNP) 实现了>90%的siRNA介导的炎症基因抑制.
- 突出了生物相容性问题,例如二氧化纳米颗粒增加了TGF-β (1.8倍, *p* <0.05).
结论:
- 纳米干预有望通过增强肺部药物输送和减少全身毒性来改善COPD治疗.
- 纳米粒子工程,肺部生物相容性和监管障碍方面的挑战必须解决临床转化.
- 未来的研究应该专注于刺激响应平台,多种疾病向和人工智能驱动的高级COPD纳米疗法个性化配方.
更多相关视频
09:07Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
Published on: July 12, 2024
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
相关概念视频
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
